Cargando…
SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway
Radiotherapy is the mainstay and primary curative treatment modality in nasopharyngeal carcinoma (NPC), whose efficacy is limited by the development of intrinsic and acquired radioresistance. Thus, deciphering new molecular targets and pathways is essential for enhancing the radiosensitivity of NPC....
Autores principales: | Nie, Xin, Guo, Ergang, Wu, Cheng, Liu, Dongbo, Sun, Wei, Zhang, Linli, Long, Guoxian, Mei, Qi, Wu, Kongming, Xiong, Huihua, Hu, Guoqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488116/ https://www.ncbi.nlm.nih.gov/pubmed/30907073 http://dx.doi.org/10.1002/cam4.2056 |
Ejemplares similares
-
Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21
por: Wu, Cheng, et al.
Publicado: (2020) -
Twist1 promotes radioresistance in nasopharyngeal carcinoma
por: Zhang, Linli, et al.
Publicado: (2016) -
Riluzole Enhances the Response of Human Nasopharyngeal Carcinoma Cells to Ionizing Radiation via ATM/P53 Signalling Pathway
por: Sun, Lu, et al.
Publicado: (2020) -
EGLN1 induces tumorigenesis and radioresistance in nasopharyngeal carcinoma by promoting ubiquitination of p53 in a hydroxylase-dependent manner
por: Sun, Lu, et al.
Publicado: (2022) -
ATM-mediated stabilization of ZEB1 promotes DNA damage response and
radioresistance through CHK1
por: Zhang, Peijing, et al.
Publicado: (2014)